Archives

by in
Entry Author Date Location
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again 10/27/11 Boston
aTyr Pharma Looks to Strike Balance Between Nonprofits, and Really Big For-Profits 07/06/11 San Diego
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News 04/01/11 Boston
Vertex CF Drug Shines in Late-Stage Study in Children 03/29/11 Boston
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News 02/25/11 Boston
Vertex Stock Up 15 Percent on CF Data 02/23/11 Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug 02/23/11 Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments 01/27/11 Boston
Vertex Raises $443M in Yet Another Monster Stock Sale 12/03/09 Boston
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey 08/07/09 National
Vertex Starts Pivotal CF Trials 05/27/09 Boston
Out With Hedge Funds, In With Blue Bloods: Vertex Transforms Investor Base Via Stock Sale 02/20/09 Boston
Vertex Raises $320M in Secondary Stock Offering 02/19/09 Boston
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days 10/20/08 Boston
Vertex Marching Ahead With Cystic Fibrosis Program 08/01/08 Boston
Page 1 of 1